www.boehringer-ingelheim.com

Eli Lilly and Company

Eli Lilly and Company is one of the world’s largest research based pharmaceutical companies. We are dedicated to creating and delivering innovative pharmaceutical health care solutions that enable people to live longer, healthier and more active lives. Lilly currently produces treatments for diabetes, schizophrenia, bipolar disorder, depression, cancer, attention deficit hyperactivity disorder, osteoporosis, erectile dysfunction and severe sepsis. The company was founded in 1876 in Indianapolis, USA, where our global headquarters remain.

 

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development.

For more information please visit www.boehringer-ingelheim.com

 

Click here to obtain a copy of THE NAPC REVIEW